C.R. Bard Release: Upcoming Presentations Related to the Lutonix Drug-Coated Balloon LEVANT 2 Trial
9/27/2013 9:25:56 AM
MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today announced two upcoming presentations related to the company’s Lutonix Drug-Coated Balloon (DCB) LEVANT 2 Trial.
Help employers find you! Check out all the jobs and post your resume.
comments powered by